]>

(a)

(b)

Figure 2: (a) The long-term effect of colestimide on LDL-C in type 2 diabetic patients ($n=34$); ${}^{*}P<.0001$ for baseline; $P>.05,$ 3 months versus end point. (b) The long-term effect of colestimide on TG in type 2 diabetic patients ($n=34$).